Business Context and Reporting Period
This Form 8-K was filed by ScanSource, Inc. on August 19, 2026. The filing primarily reports the entry into a material definitive agreement to acquire MicroAge Acquisition Corp. (MicroAge), a technology provider specializing in managed cloud, data center, cybersecurity, and IT solutions. Additionally, the filing references the announcement of financial results for the fourth quarter and fiscal year ended June 30, 2026, though the specific numerical data is contained in attached exhibits rather than the text of this report.
Key Financial Metrics and Transaction Terms
Acquisition Details:
- Purchase Price: $220.5 million in cash at closing.
- Escrow Arrangements: $3 million held for purchase price adjustments and $6.8 million held for post-closing indemnification claims.
- Target: 100% of issued and outstanding capital stock of MicroAge.
Operational Financials:
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the period ended June 30, 2026. These figures are referenced as being available in the attached Press Release (Exhibit 99.1) and Earnings Infographic (Exhibit 99.2).
Material Changes and Transaction Timeline
The primary material change is the execution of the Stock Purchase Agreement on August 19, 2026. The transaction is expected to close in September 2026, subject to customary conditions including:
- Expiration or termination of the Hart-Scott Rodino Antitrust Improvements Act waiting period.
- Receipt of necessary third-party consents.
- Satisfaction of customary closing conditions.
The agreement includes termination rights, including a provision allowing the Seller Representative to terminate if the closing has not occurred by September 1, 2026, provided the Sellers are not in material breach.
Guidance, Risks, and Management Commentary
Forward-Looking Statements: The filing contains forward-looking statements regarding the expected closing date and the strategic benefits of the acquisition. Management cautions that actual results may differ materially due to risks inherent in the transaction and the Company's business.
Risks and Contingencies:
- Termination Risk: The agreement may be terminated by mutual consent, by the Seller Representative after September 1, 2026, or by either party in the event of a material breach.
- Regulatory Risk: Closing is contingent on antitrust clearance and third-party consents.
- Integration Risk: Risks associated with the integration of MicroAge's operations are referenced in the Company's Form 10-K.
Management Commentary: No specific commentary on future guidance or outlook beyond the transaction details is provided in the text of this filing.
Investor Verification Checklist
- Verify the specific financial results for Q4 and FY 2026 by reviewing Exhibit 99.1 (Press Release) and Exhibit 99.2 (Earnings Infographic), as they are not detailed in the main text.
- Review the full Stock Purchase Agreement (Exhibit 2.1) for detailed representations, warranties, and indemnification limits.
- Monitor the status of the Hart-Scott Rodino waiting period and third-party consents to confirm the September 2026 closing timeline.
- Assess the impact of the $220.5 million cash outlay on the Company's current liquidity and debt covenants.